Nice Quarter from A...
Health Care: Drugs
POZEN Inc. (POZN: NASDAQ)
$4.57 -0.03 | -0.65%
02/09/12 - 01:46 PM ET
34.65K / 208.70K
Vol / Avg. Vol:4.60 / 4.60
Open / Prev. Close:4.56 - 4.63
Today's Range:2.15 - 6.39
52 Wk Range:16.46%
Performance YTD:TheStreet Rating:
Portfolios with POZN
- Portfolio NameUser Type
- Userwright stocks
- Contributor10 Biotech Stocks Facing FD...
- UserHouxie's stuff
- UserSnoops Millionaire Picks
- UserMMD-05-05-08_END DAY
- Usergrtdane Portfolio 1
- UserDaniel Downey's portfolio
- Userashraf999 Portfolio 1
- UserKleenex
- UserR.CUNNINGHAM
Latest POZN Headlines from TheStreet
- Pozen Incorporated Stock Downgraded (POZN) 08.02.11 | 07:08 am
- Acadia Pharmaceuticals: Investing With No Safety Net 06.24.11 | 10:06 am
- Pozen Incorporated Stock Upgraded (POZN) 03.10.11 | 05:03 pm
- Pozen CEO Discusses Q3 2010 Results - Earnings Call Transcript 10.30.10 | 04:10 pm
- Biotech Winners & Losers: Alexza, Geron 10.11.10 | 04:10 pm
- POZEN Inc Q2 2010 Earnings Call Transcript 08.03.10 | 02:08 pm
- Selling Hartford Puts; Challenges for Bulls 05.10.10 | 03:05 pm
- The InterMune Debacle Post-Script 05.05.10 | 08:05 am
- Continental, Dollar Thrifty, BP Are Active Movers 05.03.10 | 05:05 pm
- Popular, Jackson Hewitt: Midday Volume Plays 05.03.10 | 10:05 am
Press Releases for POZN
- POZEN’s Digital Advisory Board To Speak At Annual EPharma Summit - Business Wire 02.02.12 | 07:02 am
- Preventive Aspirin Use Less Than Optimal In Stroke Survivors Despite Clinical Guidelines - Business Wire 02.01.12 | 06:02 pm
- POZEN Monetizes Its Treximet Royalty Stream For $75 Million - Business Wire 11.28.11 | 07:11 am
- POZEN To Present At The Piper Jaffray 23rd Annual Healthcare Conference - Business Wire 11.17.11 | 07:11 am
- Positive Results From POZEN Phase 1 Study (“Co-Rx”) Presented At AHA - Business Wire 11.14.11 | 11:11 am
- Pozen To Present At The Lazard Capital Markets’ 8th Annual Healthcare Conference - Business Wire 11.09.11 | 07:11 am
- POZEN To Participate In The Brean Murray Carret & Co. 2011 Life Sciences Summit - Business Wire 11.08.11 | 07:11 am
- POZEN Reports Third Quarter 2011 Results - Business Wire 11.03.11 | 07:11 am
- POZEN Announces November 3, 2011 Webcast Of Third Quarter 2011 Results - Business Wire 10.20.11 | 07:10 am
- POZEN Reports Top-Line Data From Long-Term Safety Study Of PA32540 - Business Wire 10.13.11 | 07:10 am
Partner Headlines for POZN
- Pozen Has No Debt And Plenty Of Resources For 2012 NDA Filing - Seeking Alpha 11.29.11 | 09:11 am
- MICROCAP MOVERS FOR FRIDAY NOVEMBER 25, 2011 - Benzinga 11.25.11 | 04:11 pm
- UPDATE: Brean Murray Maintains Buy, Lowers PT to $7 on Pozen - Benzinga 11.25.11 | 09:11 am
- Financial Breakfast: Morning News Summary for November 25, 2011 - Benzinga 11.25.11 | 09:11 am
- IPO Preview: Horizon Pharma - Seeking Alpha 07.25.11 | 09:07 am
- Pozen Continues Fighting Off Dr. Reddy's Labs - Seeking Alpha 04.26.11 | 09:04 am
- Pozen's Success Will Depend on Execution of Unique Marketing Strategies - Seeking Alpha 03.13.11 | 09:03 am
- Pfizer's Osteoarthritis Drug Runs Into Unique Roadblock - Seeking Alpha 10.04.10 | 08:10 am
- What Will NicOx Do Next Following FDA Let-Down? - Seeking Alpha 05.13.10 | 11:05 am
- Pozen (POZN) rallies on FDA approval - ONN.TV 05.03.10 | 04:05 pm
